Algo version: 0.98b
Myovant Sciences Ltd is listed at the NYSE Exchange
Myovant Sciences Ltd [MYOV]
NYSE Sector: Healthcare Industry:Biotechnology

Is Myovant Sciences Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Myovant Sciences Ltd 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was $5.25, you would have made a profit of $21.73 per share or 413.90%

Yes, the average daily trading liquidity for Myovant Sciences Ltd is $1.09 million. You should therefore be able to get in and out of your positions relatively fast.

Myovant Sciences Ltd has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Myovant Sciences Ltd to be high [1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.